Nutex Health (NASDAQ:NUTX) Stock Price Up 7.5% – Still a Buy?

Nutex Health Inc. (NASDAQ:NUTX) shares shot up 7.5% during mid-day trading on Monday . The stock traded as high as $161.23 and last traded at $159.9170. 164,047 shares traded hands during mid-day trading, an increase of 2% from the average session volume of 160,240 shares. The stock had previously closed at $148.79.

Analyst Upgrades and Downgrades

NUTX has been the subject of a number of recent research reports. Weiss Ratings restated a “hold (c)” rating on shares of Nutex Health in a report on Monday, December 29th. Wall Street Zen upgraded shares of Nutex Health from a “buy” rating to a “strong-buy” rating in a research report on Friday, November 28th. Two research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $252.50.

Nutex Health Trading Down 19.0%

The firm’s 50 day moving average is $161.53 and its 200 day moving average is $123.07. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.20 and a quick ratio of 3.18. The company has a market capitalization of $884.46 million, a PE ratio of 6.77 and a beta of -0.01.

Nutex Health (NASDAQ:NUTX) last announced its quarterly earnings results on Tuesday, November 18th. The company reported $7.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($5.43) by $13.19. Nutex Health had a net margin of 11.62% and a return on equity of 37.44%. The business had revenue of $243.99 million for the quarter, compared to analyst estimates of $221.93 million.

Insider Transactions at Nutex Health

In other Nutex Health news, CFO Jon Christian Bates purchased 750 shares of Nutex Health stock in a transaction that occurred on Tuesday, November 25th. The shares were bought at an average price of $136.71 per share, for a total transaction of $102,532.50. Following the acquisition, the chief financial officer directly owned 5,638 shares in the company, valued at approximately $770,770.98. This trade represents a 15.34% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 36.92% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Nutex Health

Hedge funds have recently made changes to their positions in the business. Bank of America Corp DE lifted its stake in Nutex Health by 6,590.3% in the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock worth $66,000 after acquiring an additional 2,043 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of Nutex Health by 17.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company’s stock worth $852,000 after purchasing an additional 2,748 shares during the period. Jane Street Group LLC bought a new stake in shares of Nutex Health during the 1st quarter valued at about $522,000. KLP Kapitalforvaltning AS bought a new stake in shares of Nutex Health during the 2nd quarter valued at about $112,000. Finally, Clear Creek Financial Management LLC purchased a new position in shares of Nutex Health during the second quarter valued at about $397,000. 5.32% of the stock is owned by hedge funds and other institutional investors.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.